Trump’s Options to Cap Drug Prices Wane After Rebate Retreat

Bookmark
(Bloomberg) -- The Trump administration’s options for lowering high prescription-drug costs are narrowing after the White House decided to abandon a proposal that would have saddled seniors with hi...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.